Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.
Azienda Ospedaliera Universitaria "Maggiore della Carità," Novara, Italy.
Heart Rhythm. 2021 May;18(5):770-777. doi: 10.1016/j.hrthm.2021.01.010. Epub 2021 Jan 16.
Few studies have examined the causes of syncope/collapse recurrences in patients with a previously implanted pacemaker for bradyarrhythmic syncope.
The purpose of this study was to assess the causes of syncope/collapse recurrences after pacemaker implantation for bradyarrhythmic syncope in a large patient population.
The SYNCOpal recurrences in patients treated with permanent PACing for bradyarrhythmic syncope (SYNCOPACED) registry was a prospective multicenter observational registry enrolling 1364 consecutive patients undergoing pacemaker implantation for bradyarrhythmic syncope. During follow-up, the time to the first syncope/collapse recurrence was recorded. Patients with syncope/collapse recurrences underwent a predefined diagnostic workup aimed at establishing the mechanism of syncope/collapse.
During a median follow-up of 50 months, 213 patients (15.6%) reported at least 1 syncope/collapse recurrence. The risk of syncope/collapse recurrence was highest in patients who underwent implantation for cardioinhibitory vasovagal syncope (26.4%), followed by unexplained syncope and chronic bifascicular block (21.5%), cardioinhibitory carotid sinus syndrome (17.2%), atrial fibrillation needing pacing (15.5%), atrioventricular block (13.6%), and sinus node disease (12.5%) (P = .017). The most frequent cause of syncope/collapse recurrence was reflex syncope (27.7%), followed by orthostatic hypotension (26.3%), pacemaker or lead malfunction (5.6%), structural cardiac disease (5.2%), and atrial and ventricular tachyarrhythmias (4.7% and 3.8%, respectively). In 26.8% of cases, the mechanism of syncope/collapse remained unexplained.
In patients receiving a pacemaker for bradyarrhythmic syncope, reflex syncope and orthostatic hypotension are the most frequent mechanisms of syncope/collapse recurrence after implantation. Pacing system malfunction, structural cardiac diseases, and tachyarrhythmias are rare mechanisms. The mechanism remains unexplained in >25% of patients.
很少有研究探讨先前因心动过缓性晕厥植入起搏器的患者晕厥/晕厥复发的原因。
本研究旨在评估大量患者人群中因心动过缓性晕厥植入起搏器后晕厥/晕厥复发的原因。
SYNCOpal 复发患者接受永久性起搏治疗心动过缓性晕厥(SYNCOPACED)登记研究是一项前瞻性多中心观察性登记研究,纳入 1364 例因心动过缓性晕厥接受起搏器植入的连续患者。在随访期间,记录首次晕厥/晕厥复发的时间。有晕厥/晕厥复发的患者接受了预先定义的诊断性检查,旨在确定晕厥/晕厥的机制。
在中位随访 50 个月期间,213 例(15.6%)患者报告至少发生 1 次晕厥/晕厥复发。因心脏抑制性血管迷走神经性晕厥植入起搏器的患者晕厥/晕厥复发风险最高(26.4%),其次是不明原因晕厥和慢性双束支阻滞(21.5%)、心脏抑制性颈动脉窦综合征(17.2%)、需要起搏的心房颤动(15.5%)、房室传导阻滞(13.6%)和窦房结疾病(12.5%)(P=0.017)。晕厥/晕厥复发的最常见原因是反射性晕厥(27.7%),其次是直立性低血压(26.3%)、起搏器或导线故障(5.6%)、结构性心脏病(5.2%)和房性和室性心动过速(分别为 4.7%和 3.8%)。在 26.8%的病例中,晕厥/晕厥的机制仍未得到解释。
在因心动过缓性晕厥接受起搏器治疗的患者中,反射性晕厥和直立性低血压是植入后晕厥/晕厥复发的最常见机制。起搏系统故障、结构性心脏病和心动过速很少见。>25%的患者机制仍未得到解释。